EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.37B
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
489
New
Increased
Reduced
Closed

Top Buys

1 +$483M
2 +$247M
3 +$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Healthcare 4.63%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
API
451
Agora
API
$338M
$193K 0.01%
+54,555
IOVA icon
452
Iovance Biotherapeutics
IOVA
$1.59B
$191K 0.01%
+54,429
RLAY icon
453
Relay Therapeutics
RLAY
$3B
$188K 0.01%
+18,933
QURE icon
454
uniQure
QURE
$1.1B
$186K 0.01%
+11,348
ORIC icon
455
Oric Pharmaceuticals
ORIC
$1.2B
$184K 0.01%
+14,517
MNKD icon
456
MannKind Corp
MNKD
$877M
$179K 0.01%
+73,100
TSHA icon
457
Taysha Gene Therapies
TSHA
$1.85B
$169K 0.01%
+37,699
GERN icon
458
Geron
GERN
$1.08B
$165K ﹤0.01%
+111,070
F icon
459
Ford
F
$51.6B
$161K ﹤0.01%
+13,975
PGEN icon
460
Precigen
PGEN
$1.41B
$155K ﹤0.01%
+40,126
VIR icon
461
Vir Biotechnology
VIR
$1.73B
$151K ﹤0.01%
+16,896
CTMX icon
462
CytomX Therapeutics
CTMX
$1.04B
$142K ﹤0.01%
+30,147
ANNX icon
463
Annexon
ANNX
$1.05B
$142K ﹤0.01%
+25,552
KURA icon
464
Kura Oncology
KURA
$859M
$137K ﹤0.01%
+16,864
SLS icon
465
SELLAS Life Sciences
SLS
$937M
$133K ﹤0.01%
+31,354
CMPX icon
466
Compass Therapeutics
CMPX
$1.08B
$130K ﹤0.01%
+24,622
SVRA icon
467
Savara
SVRA
$1.18B
$130K ﹤0.01%
+23,752
SANA icon
468
Sana Biotechnology
SANA
$939M
$128K ﹤0.01%
+44,446
SPRY icon
469
ARS Pharmaceuticals
SPRY
$812M
$119K ﹤0.01%
+14,787
REPL icon
470
Replimune Group
REPL
$179M
$114K ﹤0.01%
+14,893
IRWD icon
471
Ironwood Pharmaceuticals
IRWD
$722M
$95.6K ﹤0.01%
+27,230
PRME icon
472
Prime Medicine
PRME
$688M
$94.3K ﹤0.01%
+27,099
ABSI icon
473
Absci
ABSI
$548M
$90.9K ﹤0.01%
+30,290
ALT icon
474
Altimmune
ALT
$455M
$89.5K ﹤0.01%
+29,072
EBS icon
475
Emergent Biosolutions
EBS
$455M
$88.9K ﹤0.01%
+10,710